System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe
- PMID: 16195297
- PMCID: PMC1239984
- DOI: 10.1136/bmj.331.7519.765
System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe
Abstract
Low cost and effective drugs, such as magnesium sulphate, need to be included in initiatives to improve access to essential medicines in Africa
Figures
References
-
- World Health Organization. Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Geneva, Switzerland: WHO, 2001.
-
- Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 2002;359: 2188-94. - PubMed
-
- World Health Organization. Priority medicines for Europe and the world. Geneva, Switzerland: WHO, 2004.
-
- Olliaro P, Smith P. The European and developing countries clinical trials partnership. J HIV Ther 2004;9: 53-6. - PubMed
-
- United Nations. United Nations millennium declaration. United Nations General Assembly resolution 55/2. New York, NY: UN, 2000.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources